Opportunity Information: Apply for PAS 15 055
Apply for PAS 15 055
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "High Priority Immunology Grants (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855 Allergy and Infectious Diseases Research 93.856 Microbiology and Infectious Diseases Research.
- This funding opportunity was created on Dec 4, 2014 and posted on Dec 4, 2014.
- Applicants must submit their applications by Jan 7, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $15,000,000.00 to eligible and selected applicants.
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education Small businesses Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments City or township governments Native American tribal organizations (other than Federally recognized tribal governments).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The High Priority Immunology Grants (R01) funding opportunity (PAS 15-055) is a discretionary NIH grant program designed to strengthen and expand the National Institute of Allergy and Infectious Diseases (NIAID) portfolio of investigator-initiated R01 awards in fundamental immunology. The central purpose is not to launch a narrow, one-off initiative, but to help sustain long-term growth in core immunology research supported through the standard R01 mechanism. The announcement was created in response to a documented drop in both the number of immunology-focused R01 applications submitted to NIAID and the number ultimately funded over several fiscal years, and it aims to counter that trend by encouraging more high-quality proposals in foundational immunology.
This opportunity uses the R01 research project grant mechanism, meaning it is geared toward well-developed, hypothesis-driven projects that can make substantial contributions to the field. It falls under NIH health-related research activity and is associated with CFDA numbers 93.855 (Allergy and Infectious Diseases Research) and 93.856 (Microbiology and Infectious Diseases Research). The estimated total funding listed for the program is $15,000,000, and the program does not require cost sharing or matching, which lowers barriers for applicants who might otherwise struggle to provide non-federal funds.
Eligibility is broad and includes many types of domestic organizations that commonly apply for NIH research grants. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including those with 501(c)(3) status and certain nonprofits without 501(c)(3) status), small businesses, and for-profit organizations (other than small businesses). Government entities such as state governments, county governments, and city or township governments are also eligible, along with special district governments and independent school districts. The announcement also explicitly recognizes a wide range of mission-driven and community-centered institutions and organizations as eligible, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations and eligible federal agencies.
At the same time, there are clear limits on non-U.S. participation. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the primary applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, the FOA allows foreign components as defined by the NIH Grants Policy Statement, which means a U.S.-based applicant can include certain international elements of the work when scientifically justified and consistent with NIH policy.
From an administrative timeline perspective, the opportunity was posted on December 4, 2014, and it remained open through a closing date of January 7, 2018, with an archive date of February 7, 2018. The sponsoring agency is the National Institutes of Health, with NIAID as the relevant institute given the program’s focus on immunology within allergy and infectious diseases research. For applicants or readers who needed help accessing the full announcement, the contact pathway listed is the NIH Office of Extramural Research (OER) Webmaster. The additional information link provided in the record points to the NIH grants guide page for PAS 15-055, which is where full details such as scientific scope, application instructions, review considerations, and award policies would be found.
Frequently Asked Questions (FAQs)
What is the High Priority Immunology Grants (R01) opportunity (PAS 15-055)?
PAS 15-055 is a discretionary NIH funding opportunity designed to strengthen and expand the National Institute of Allergy and Infectious Diseases (NIAID) portfolio of investigator-initiated R01 awards in fundamental immunology. It uses the NIH R01 research project grant mechanism.
What is the main goal of this funding opportunity?
The central purpose is to sustain long-term growth in core immunology research supported through the standard R01 mechanism. It is not intended as a narrow, one-off initiative, but rather as a way to encourage more high-quality, foundational immunology proposals to NIAID.
Why was PAS 15-055 created?
The announcement was created in response to a documented drop over several fiscal years in both (1) the number of immunology-focused R01 applications submitted to NIAID and (2) the number of those applications ultimately funded. The opportunity aims to counter that trend by encouraging additional strong applications in fundamental immunology.
Which grant mechanism does this opportunity use?
This opportunity uses the NIH R01 research project grant mechanism, which is generally intended for well-developed, hypothesis-driven research projects that can make substantial contributions to a scientific field.
Which NIH institute is most directly associated with this program?
The National Institutes of Health (NIH) is the sponsoring agency, and the National Institute of Allergy and Infectious Diseases (NIAID) is the relevant institute given the program focus on immunology within allergy and infectious diseases research.
What scientific area does this funding opportunity emphasize?
The program emphasizes fundamental (foundational) immunology and is intended to expand NIAID support for investigator-initiated immunology research through R01 awards.
What is the estimated total funding amount listed for this program?
The estimated total funding listed for the program is $15,000,000.
Is cost sharing or matching required?
No. The program does not require cost sharing or matching, which can reduce barriers for applicants that may not have access to non-federal funds.
What CFDA numbers are associated with PAS 15-055?
This opportunity is associated with CFDA 93.855 (Allergy and Infectious Diseases Research) and CFDA 93.856 (Microbiology and Infectious Diseases Research).
What types of U.S. organizations are eligible to apply?
Eligibility is broad and includes domestic organizations such as public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including those with 501(c)(3) status and certain nonprofits without 501(c)(3) status), small businesses, and for-profit organizations (other than small businesses).
Are government entities eligible to apply?
Yes. Eligible government applicants include state governments, county governments, city or township governments, special district governments, and independent school districts.
Are mission-driven and community-centered institutions explicitly recognized as eligible?
Yes. The announcement explicitly recognizes eligibility for a range of institutions and organizations, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also notes faith-based or community-based organizations and eligible federal agencies.
Can non-U.S. (foreign) organizations apply as the primary applicant?
No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the primary applicant organization under this opportunity.
Are non-domestic components of U.S. organizations eligible to apply?
No. Non-domestic components of U.S. organizations are also not eligible to apply as the applicant organization.
Are foreign components allowed in projects submitted by eligible U.S. applicants?
Yes. The FOA allows foreign components as defined by the NIH Grants Policy Statement, meaning a U.S.-based applicant may include certain international elements of the work when scientifically justified and consistent with NIH policy.
When was this funding opportunity posted?
The opportunity was posted on December 4, 2014.
What was the closing date for applications?
The closing date listed for the opportunity was January 7, 2018.
When was the opportunity archived?
The archive date listed for the opportunity was February 7, 2018.
Where can applicants find the full announcement and official instructions?
The record points to the NIH grants guide page for PAS 15-055 as the source for full details, including scientific scope, application instructions, review considerations, and award policies.
Who is listed as the contact for help accessing the full announcement?
The contact pathway listed is the NIH Office of Extramural Research (OER) Webmaster.
Is this opportunity intended for early-stage ideas or more developed research projects?
Because it uses the R01 mechanism, it is geared toward well-developed, hypothesis-driven projects that can make substantial contributions to the field.
Is this program focused on creating a targeted, narrow initiative?
No. The stated intent is to avoid launching a narrow, one-off initiative and instead support sustained growth in core immunology research through standard R01 awards.
Browse more opportunities from the same category: Health
Next opportunity: Perinatal and Infant Oral Health Quality Improvement Expansion Grant Program
Previous opportunity: 15.PMWRA. SALW Training Support. RFA
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAS 15 055
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAS 15 055) also looked into and applied for these:
| Funding Opportunity |
|---|
| Perinatal and Infant Oral Health Quality Improvement Expansion Grant Program Apply for HRSA 15 070 Funding Number: HRSA 15 070 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Advanced Nursing Education Program Apply for HRSA 15 046 Funding Number: HRSA 15 046 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R21) Apply for PA 15 057 Funding Number: PA 15 057 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R01) Apply for PA 15 058 Funding Number: PA 15 058 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Clinical Trial or Biomarker Clinical Validation Study Cooperative Agreement (U01) Apply for PAR 15 059 Funding Number: PAR 15 059 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Predoctoral Training in General, Pediatric and Public Health Dentistry and Dental Hygiene Apply for HRSA 15 050 Funding Number: HRSA 15 050 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Asthma Empowerment Collaborations to Reduce Childhood Asthma Disparities (U01) Apply for RFA HL 17 001 Funding Number: RFA HL 17 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epi Centers for the Prevention of Healthcare Associated Infections, Antimicrobial Resistance and Adverse Events A Multicenter Program Expansion (U54) Apply for RFA CK 11 0010501SUPP15 Funding Number: RFA CK 11 0010501SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Creating Asthma Empowerment Collaborations to Reduce Childhood Asthma Disparities (U34) Apply for RFA HL 15 028 Funding Number: RFA HL 15 028 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Radiological/Nuclear Medical Countermeasure Product Development Program (R43/R44) Apply for PA 15 065 Funding Number: PA 15 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Postdoctoral Training in General, Pediatric, and Public Health Dentistry Apply for HRSA 15 051 Funding Number: HRSA 15 051 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Nurse Anesthetist Traineeship Program (NAT) Apply for HRSA 15 047 Funding Number: HRSA 15 047 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Assay Development and Therapeutic Agent Identification and Characterization to Support Therapeutic Discovery (R21/R33) Apply for PAR 15 070 Funding Number: PAR 15 070 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Pharmacodynamics and In vivo Efficacy Studies for Small Molecules and Biologics/Biotechnology Products (R21/R33) Apply for PAR 15 071 Funding Number: PAR 15 071 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| NINDS Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50) Apply for RFA NS 15 002 Funding Number: RFA NS 15 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Positive Health Check Evaluation Trial Apply for RFA PS 15 001 Funding Number: RFA PS 15 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Mobile Messaging Intervention to Present New HIV Prevention Apply for RFA PS 15 002 Funding Number: RFA PS 15 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| NIMH Administrative Supplement Program Providing Research Experiences for Physicians and Medical Students from Diverse Backgrounds Apply for PA 15 069 Funding Number: PA 15 069 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY15 FY16 Department of Defense HIV/AIDS Prevention Program Military Specific HIV/AIDS Prevention, Care, and Treatment Program for non PEPFAR (Presidents Emergency Plan for AIDS Relief Apply for DHAPP BAA 15 001 Funding Number: DHAPP BAA 15 001 Agency: Naval Supply Systems Command Category: Health Funding Amount: Case Dependent |
| Centers for Common Disease Genomics (UM1) Apply for RFA HG 15 001 Funding Number: RFA HG 15 001 Agency: National Institutes of Health Category: Health Funding Amount: $40,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAS 15 055", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.